List of Tables
Table 1. Global Glioma Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Glioma Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Glioma Treatment Market Competitive Situation by Manufacturers in 2023
Table 4. Global Glioma Treatment Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Glioma Treatment Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Glioma Treatment Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Glioma Treatment Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Glioma Treatment Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Glioma Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Glioma Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Glioma Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Glioma Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Glioma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glioma Treatment as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Glioma Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Glioma Treatment Sales by Region (2019-2024) & (K Units)
Table 18. Global Glioma Treatment Sales Market Share by Region (2019-2024)
Table 19. Global Glioma Treatment Sales by Region (2025-2030) & (K Units)
Table 20. Global Glioma Treatment Sales Market Share by Region (2025-2030)
Table 21. Global Glioma Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Glioma Treatment Revenue Market Share by Region (2019-2024)
Table 23. Global Glioma Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Glioma Treatment Revenue Market Share by Region (2025-2030)
Table 25. North America Glioma Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Glioma Treatment Sales by Country (2019-2024) & (K Units)
Table 27. North America Glioma Treatment Sales by Country (2025-2030) & (K Units)
Table 28. North America Glioma Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Glioma Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Glioma Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Glioma Treatment Sales by Country (2019-2024) & (K Units)
Table 32. Europe Glioma Treatment Sales by Country (2025-2030) & (K Units)
Table 33. Europe Glioma Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Glioma Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Glioma Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Glioma Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Glioma Treatment Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Glioma Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Glioma Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Glioma Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Glioma Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Glioma Treatment Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Glioma Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Glioma Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Glioma Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Glioma Treatment Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Glioma Treatment Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Glioma Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Glioma Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Glioma Treatment Sales (K Units) by Type (2019-2024)
Table 51. Global Glioma Treatment Sales (K Units) by Type (2025-2030)
Table 52. Global Glioma Treatment Sales Market Share by Type (2019-2024)
Table 53. Global Glioma Treatment Sales Market Share by Type (2025-2030)
Table 54. Global Glioma Treatment Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Glioma Treatment Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Glioma Treatment Revenue Market Share by Type (2019-2024)
Table 57. Global Glioma Treatment Revenue Market Share by Type (2025-2030)
Table 58. Global Glioma Treatment Price (US$/Unit) by Type (2019-2024)
Table 59. Global Glioma Treatment Price (US$/Unit) by Type (2025-2030)
Table 60. Global Glioma Treatment Sales (K Units) by Application (2019-2024)
Table 61. Global Glioma Treatment Sales (K Units) by Application (2025-2030)
Table 62. Global Glioma Treatment Sales Market Share by Application (2019-2024)
Table 63. Global Glioma Treatment Sales Market Share by Application (2025-2030)
Table 64. Global Glioma Treatment Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Glioma Treatment Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Glioma Treatment Revenue Market Share by Application (2019-2024)
Table 67. Global Glioma Treatment Revenue Market Share by Application (2025-2030)
Table 68. Global Glioma Treatment Price (US$/Unit) by Application (2019-2024)
Table 69. Global Glioma Treatment Price (US$/Unit) by Application (2025-2030)
Table 70. Sun Pharmaceutical Corporation Information
Table 71. Sun Pharmaceutical Description and Business Overview
Table 72. Sun Pharmaceutical Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Sun Pharmaceutical Glioma Treatment Product
Table 74. Sun Pharmaceutical Recent Developments/Updates
Table 75. Amgen Corporation Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Amgen Glioma Treatment Product
Table 79. Amgen Recent Developments/Updates
Table 80. Teva Pharmaceutical Corporation Information
Table 81. Teva Pharmaceutical Description and Business Overview
Table 82. Teva Pharmaceutical Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Teva Pharmaceutical Glioma Treatment Product
Table 84. Teva Pharmaceutical Recent Developments/Updates
Table 85. Bristol-Myers Squibb Corporation Information
Table 86. Bristol-Myers Squibb Description and Business Overview
Table 87. Bristol-Myers Squibb Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Bristol-Myers Squibb Glioma Treatment Product
Table 89. Bristol-Myers Squibb Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Pfizer Glioma Treatment Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Merck Corporation Information
Table 96. Merck Description and Business Overview
Table 97. Merck Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Merck Glioma Treatment Product
Table 99. Merck Recent Developments/Updates
Table 100. Eli Lilly Corporation Information
Table 101. Eli Lilly Description and Business Overview
Table 102. Eli Lilly Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Eli Lilly Glioma Treatment Product
Table 104. Eli Lilly Recent Developments/Updates
Table 105. F. Hoffmann-La Roche Ltd Corporation Information
Table 106. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 107. F. Hoffmann-La Roche Ltd Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. F. Hoffmann-La Roche Ltd Glioma Treatment Product
Table 109. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 110. AbbVie Corporation Information
Table 111. AbbVie Description and Business Overview
Table 112. AbbVie Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. AbbVie Glioma Treatment Product
Table 114. AbbVie Recent Developments/Updates
Table 115. Genentech Corporation Information
Table 116. Genentech Description and Business Overview
Table 117. Genentech Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Genentech Glioma Treatment Product
Table 119. Genentech Recent Developments/Updates
Table 120. BioMimetix Corporation Information
Table 121. BioMimetix Description and Business Overview
Table 122. BioMimetix Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. BioMimetix Glioma Treatment Product
Table 124. BioMimetix Recent Developments/Updates
Table 125. Cipla Corporation Information
Table 126. Cipla Description and Business Overview
Table 127. Cipla Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Cipla Glioma Treatment Product
Table 129. Cipla Recent Developments/Updates
Table 130. Sigma-Aldrich Corporation Information
Table 131. Sigma-Aldrich Description and Business Overview
Table 132. Sigma-Aldrich Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Sigma-Aldrich Glioma Treatment Product
Table 134. Sigma-Aldrich Recent Developments/Updates
Table 135. Panacea Biotec Corporation Information
Table 136. Panacea Biotec Description and Business Overview
Table 137. Panacea Biotec Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Panacea Biotec Glioma Treatment Product
Table 139. Panacea Biotec Recent Developments/Updates
Table 140. Zydus Cadila Corporation Information
Table 141. Zydus Cadila Description and Business Overview
Table 142. Zydus Cadila Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Zydus Cadila Glioma Treatment Product
Table 144. Zydus Cadila Recent Developments/Updates
Table 145. Takeda Pharmaceuticals Corporation Information
Table 146. Takeda Pharmaceuticals Description and Business Overview
Table 147. Takeda Pharmaceuticals Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Takeda Pharmaceuticals Glioma Treatment Product
Table 149. Takeda Pharmaceuticals Recent Developments/Updates
Table 150. Boston Biomedical Corporation Information
Table 151. Boston Biomedical Description and Business Overview
Table 152. Boston Biomedical Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Boston Biomedical Glioma Treatment Product
Table 154. Boston Biomedical Recent Developments/Updates
Table 155. Ziopharm Oncology Corporation Information
Table 156. Ziopharm Oncology Description and Business Overview
Table 157. Ziopharm Oncology Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Ziopharm Oncology Glioma Treatment Product
Table 159. Ziopharm Oncology Recent Developments/Updates
Table 160. Celldex Therapeutics Corporation Information
Table 161. Celldex Therapeutics Description and Business Overview
Table 162. Celldex Therapeutics Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Celldex Therapeutics Glioma Treatment Product
Table 164. Celldex Therapeutics Recent Developments/Updates
Table 165. BERG Corporation Information
Table 166. BERG Description and Business Overview
Table 167. BERG Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. BERG Glioma Treatment Product
Table 169. BERG Recent Developments/Updates
Table 170. Oncorus Corporation Information
Table 171. Oncorus Description and Business Overview
Table 172. Oncorus Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. Oncorus Glioma Treatment Product
Table 174. Oncorus Recent Developments/Updates
Table 175. Agenus Corporation Information
Table 176. Agenus Description and Business Overview
Table 177. Agenus Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 178. Agenus Glioma Treatment Product
Table 179. Agenus Recent Developments/Updates
Table 180. Deciphera Pharmaceuticals Corporation Information
Table 181. Deciphera Pharmaceuticals Description and Business Overview
Table 182. Deciphera Pharmaceuticals Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 183. Deciphera Pharmaceuticals Glioma Treatment Product
Table 184. Deciphera Pharmaceuticals Recent Developments/Updates
Table 185. Karyopharm Therapeutics Corporation Information
Table 186. Karyopharm Therapeutics Description and Business Overview
Table 187. Karyopharm Therapeutics Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 188. Karyopharm Therapeutics Glioma Treatment Product
Table 189. Karyopharm Therapeutics Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Glioma Treatment Distributors List
Table 193. Glioma Treatment Customers List
Table 194. Glioma Treatment Market Trends
Table 195. Glioma Treatment Market Drivers
Table 196. Glioma Treatment Market Challenges
Table 197. Glioma Treatment Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Glioma Treatment
Figure 2. Global Glioma Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Glioma Treatment Market Share by Type in 2023 & 2030
Figure 4. ChemOthersapy Product Picture
Figure 5. Drugs Product Picture
Figure 6. Global Glioma Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Glioma Treatment Market Share by Application in 2023 & 2030
Figure 8. Hospitals
Figure 9. Cancer Research Organizations
Figure 10. Diagnostic Centers
Figure 11. Others
Figure 12. Global Glioma Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Glioma Treatment Market Size (2019-2030) & (US$ Million)
Figure 14. Global Glioma Treatment Sales (2019-2030) & (K Units)
Figure 15. Global Glioma Treatment Average Price (US$/Unit) & (2019-2030)
Figure 16. Glioma Treatment Report Years Considered
Figure 17. Glioma Treatment Sales Share by Manufacturers in 2023
Figure 18. Global Glioma Treatment Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Glioma Treatment Players: Market Share by Revenue in 2023
Figure 20. Glioma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Glioma Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Glioma Treatment Sales Market Share by Country (2019-2030)
Figure 23. North America Glioma Treatment Revenue Market Share by Country (2019-2030)
Figure 24. United States Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Glioma Treatment Sales Market Share by Country (2019-2030)
Figure 27. Europe Glioma Treatment Revenue Market Share by Country (2019-2030)
Figure 28. Germany Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Glioma Treatment Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Glioma Treatment Revenue Market Share by Region (2019-2030)
Figure 35. China Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Glioma Treatment Sales Market Share by Country (2019-2030)
Figure 45. Latin America Glioma Treatment Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Glioma Treatment Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Glioma Treatment Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Glioma Treatment by Type (2019-2030)
Figure 55. Global Revenue Market Share of Glioma Treatment by Type (2019-2030)
Figure 56. Global Glioma Treatment Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Glioma Treatment by Application (2019-2030)
Figure 58. Global Revenue Market Share of Glioma Treatment by Application (2019-2030)
Figure 59. Global Glioma Treatment Price (US$/Unit) by Application (2019-2030)
Figure 60. Glioma Treatment Value Chain
Figure 61. Glioma Treatment Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
